KWALITY PHARMACEUTICALS
Back to Balance Sheet
|
KWALITY PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-0.03 Cr | ₹0.41 Cr | ₹0.28 Cr | ₹-0.04 Cr | ₹-0.20 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of KWALITY PHARMACEUTICALS ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹-0.03 Cr |
Mar2023 | ₹0.41 Cr |
Mar2022 | ₹0.28 Cr |
Mar2021 | ₹-0.04 Cr |
Mar2020 | ₹-0.20 Cr |
How is Deferred Tax Assets / Liabilities of KWALITY PHARMACEUTICALS Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹-0.03 Cr | Negative | |
Mar2023 | ₹0.41 Cr | 49.45 | |
Mar2022 | ₹0.28 Cr | Positive | |
Mar2021 | ₹-0.04 Cr | Negative | |
Mar2020 | ₹-0.20 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of KWALITY PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KWALITY PHARMACEUTICALS | ₹785.7 Cr | -3.1% | -16.6% | 68.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹409,003.0 Cr | -0.2% | -1% | 9.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹154,939.0 Cr | -2.1% | 1.5% | 61.3% | Stock Analytics | |
CIPLA | ₹117,835.0 Cr | -0% | 2% | -0.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,784.6 Cr | -1.4% | -6.1% | -4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹90,722.1 Cr | -5.2% | -4.7% | 8.9% | Stock Analytics |
KWALITY PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KWALITY PHARMACEUTICALS | -3.1% |
-16.6% |
68.5% |
SENSEX | -2.5% |
-1.4% |
6.1% |
You may also like the below Video Courses